NEW YORK, Dec. 7 (GenomeWeb News) - Shares in Ciphergen Biosystems were up 26.5 percent at $4.20 in unusually heavy volume late this afternoon after the company said its technology could be used to detect certain cancers in platelets.
...and receive Daily News bulletins.
Already have an account?Login Now.
Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.
The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.
Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.
In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.